[Methods for androgen receptor splice variant-7 detection: Advances in studies].

Kun Li1, Guang-Rui Fan1, Chao-Hu Chen1

  • 1Research Institute of Urology / Key Laboratory of Gansu Province for Urinary System Diseases / Gansu Provincial Center of Clinical Medicine for Urinary System Diseases, Lanzhou University Second Hospital, Lanzhou, Gansu 730030, China.

Summary

Androgen receptor splice variant-7 (AR-V7) shows promise as a biomarker for predicting treatment response in castration-resistant prostate cancer (CRPC). Current detection methods need refinement for widespread clinical use.